9 th July 2019 – Global Disposable Syringe Market research report provides a specific tool for evaluating the Industry, highlighting opportunities, and supporting strategic and tactical decision-making. This study identifies that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and development. It provides information on trends and developments, and focuses on markets capacities and on the changing structure of the Disposable Syringe. In addition, the research evaluated key market aspects, comprising capacity utilization rate, revenue, price, capacity, growth rate, gross, production, consumption, supply, export, market share, cost, import, gross margin, demand, and much more. Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/disposable-syringe-market-outlook/request-sample Global disposable syringe market is expected to grow a...
Global
Atherectomy Devices Market is expected to witness rapid growth over the
forecast period. Increase in prevalence of Peripheral artery disease (PAD) and
Deep vein thrombosis (DVT) is expected to drive the market growth over the
forecast period. Increase in aging population in the US and in economically
developed countries resulting in high requirement of medical devices for
chronic illness. This is expected to escalate the market growth of Atherectomy
devices. Major factors such as rising life expectancy declining fertility rates
play a major role in Atherectomy Devices Market growth in the foreseeable
future. Change in lifestyle trends and eating habits increase Consumption of
cholesterol and fatty foods among individuals and lack of exercise which has
been a major reason for coronary artery disease and high risk of heart attacks.
Depending on the severity of the health issue atherectomy devices are used in
the surgery by the doctors.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/atherectomy-devices-market
Diabetes,
high blood pressure, obesity and smoking causes the blood arteries to marrow
and limit the blood supply to the heart. It is estimated that 382 billion
people throughout the world have diabetes. Environmental factors such as foods,
viruses, toxins and unbalanced work life play a role in development of
diabetes. Growing number of patients with these vascular diseases are expected
to proliferate the demand for atherectomy devices. Adopting advanced technology
by using laser, ultraviolet radiation and recombinant issue technology and 3D
image generation provides a better scope for the Atherectomy devices market.
Added benefits such as minimal incisions, higher surgical restoration rate, low
postoperative complications increase more patients opting for atherectomy
devices.
New
technological advancements and the recent FDA approval of Two drug coated
balloons are increasing atherectomy procedural volume and driving growth in the
demand for atherectomy devices Recalls of medical devices has beena major issue
in pharmaceutical industry. Every device should maintain the standard quality
and safety measures set by the Food and Drug Administration (FDA). All the
manufacturing firms should ensure that the products are safe and do not
endanger the end consumer. Athrectomy devices face a tough competition from
Catheter (Tornus) which has been developed for chronic total occlusion
recanalization. However, Catheter has a lower success rate of only 77% as
compared to the traditional atherectomy devices with 95%. Tornus catheter is
also associated with longer procedural duration time with 144 minutes versus
the atherectomy devices 115 minutes.
Lack
of product differentiation forms a major challenge in the atherectomy Devices
market. Most companies trying to enter the market find it hard to overcome the
product differentiation because they require high investment and lack resources
to create products that can compete with the existing ones. High cost and
limited awareness in certain regions of the world act as a restraint for the
market growth. Atherectomy technique is
a popular substitute for stents and angioplasty treatments. In stents and
angioplasty, the deposited plaque is pushed inside the blood vessel, however in
atherectomy the plaque is removed by using surgical methods. The technique has
advantages over the other methods by providing increased wound healing
rate The Atherectomy Devices Market has
been classified on the basis of its device functions such as rotational,
orbital, excimer laser, excisional, directional and Jetstream atherectomy. The
largest share of the market is occupied by orbital and directional atherectomy
due to minimal invasive treatment, blood flow restoration, reduction in
procedure time and application in more complex cases. Market players are coming
with better techniques and products to meet the requirement of the consumers.
The
Atherectomy Devices Market is segmented on the basis of geography such as North
America, Europe, Asia pacific. North America is the leading player in the
market followed by Europe. Peripheral artery disease affects nearly 10 million
people and around 720,000 die every year due to heart attack in US making it
the potential market for the devices. Higher number of surgeries are being
performed in US and Europe due to better awareness among people and also availability
of resources making them the leading regions in the market. Asia pacific can be
a potential market for atherectomy devices since countries such as India and
china possess the largest number of cardiac patients with an annual incidence
of 7 million strokes. Tobacco consumption is rapidly increasing in south Asian
countries in conjunction with economic expansion increasing their risk of
artery diseases.
Reduction
of abdominal obesity through lifestyle measures can improve all components of
the metabolic syndrome and likely delay the development of both diabetes and
atherosclerosis. Beyond lifestyle intervention, optimal management of risk
factors to evidence-based targets is essential. High awareness of health
problems caused due to change in lifestyle and optimal management of risk
factors can improve the metabolic syndrome and likely reduce the development of
both diabetes and atherosclerosis and hence reducing the demand for the
atherectomy devices. The major companies of the Atherectomy Devices Market
include Bayer AG, Cardiovascular systems, St. Jude medica, Boston scientific
corporation, Abbott laboratories, C.R Bard Inc., Volcano Corporation. The
competition in this Atherectomy Devices Market usually depends on the
technology used in manufacturing of the devices and also the pricing
strategies. Medtronic’s is leading competitor in peripheral atherectomy
devices. Medtronic acquired Covedian in 2015 and is expected to remain in the
leading position however it will face increasing competition from cardiovascular
systems Inc.
Request a Free Sample Copy
of This Report @ https://www.millioninsights.com/industry-reports/atherectomy-devices-market/request-sample

Comments
Post a Comment